University spin-off Oxford Nanopore plans to list in London
DNA sequencing group could be valued at £4bn in UK float
30 March 2021 - 23:57
DNA sequencing firm
DNA sequencing firm Oxford Nanopore Technologies plans to list on the London Stock Exchange (LSE) in the second half of the year, delivering a major win for the City in its effort to position itself as an attractive venue for initial public offerings (IPO) in a post-Brexit world.
A listing will give the company access to “deeper, international pools of capital” for its growth plans, Oxford Nanopore said in a statement on its website on Tuesday. The timing of the IPO is dependent on market conditions, it said...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.